Live Breaking News & Updates on Dynamx Coronary Bioadaptor Technology

Stay updated with breaking news from Dynamx coronary bioadaptor technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Elixir Medical To Present Randomized Clinical Dataset Featuring World's First Triple Drug-Eluting Coronary Implant Eluting Two Anticoagulants and Sirolimus at TCT 2023

Primary endpoint, six-month clinical and imaging data from clinical trial of DESyne BDS Plus stent system evaluating safety and efficacy of localized delivery of anticoagulants and an anti-proliferative agent designed to reduce the implant thrombotic risk ....

New Zealand , San Francisco , United States , Roxana Mehran , Stefan Verheye , Robertw Yeh , Motasim Sirhan , Mirvat Alasnag , Mark Webster , Ignacio Cruz Gonzalez , David Erlinge , Dynamx Hong Kong , Clinical Science Research , Clinical Science Research Sessions , Moscone Center , Innovation Program , Dynamx Coronary Bioadaptor Technology , Elixir Medical , Randomized Clinical Trial , Transcatheter Cardiovascular Therapeutics , Coronary Disease Diagnosis , Clinical Science Theater , Six Month Clinical , Imaging Results , Improved Outcomes Require , Presentation Theater ,